Skip to content

  • Home
  • About Ampersand
  • About PRIM&R
  • Posts
  • Contact Us
  • Policies

Tag: FDA Reauthorization Act

> FDA Reauthorization Act
Uncategorized

PRIM&R’s Response to FDA’s Draft Guidance on Enhancing the Diversity of Clinical Trial Populations

(PRIM&R) Public Responsibility in Medicine and Research

In June, the Food and Drug Administration (FDA) issued a draft guidance, "Enhancing the Diversity of Clinical Trial Populations—Eligibility Criteria,…

Read More
Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Search the blog
Blogs of Interest

PCORI Blog

RAPS Focus

Bill of Health

BioEdge

ACRP Blog

PRIM&R advances the highest ethical standards in the conduct of research. We accomplish this mission through education, membership services, professional certification, public policy initiatives, and community building.